Medidata Solutions Given New $93.00 Price Target at B. Riley (MDSO)
Investment analysts at B. Riley increased their price objective on shares of Medidata Solutions (NASDAQ:MDSO) from $75.00 to $93.00 in a note issued to investors on Tuesday, ARN reports. The firm currently has a “neutral” rating on the stock. B. Riley’s price objective indicates a potential downside of 11.23% from the company’s current price.
MDSO has been the subject of a number of other recent research reports. Analysts at Credit Suisse raised their price target on shares of Medidata Solutions from $94.00 to $108.00 in a research note to investors on Friday, September 13th. Separately, analysts at Raymond James raised their price target on shares of Medidata Solutions from $50.00 to $58.00 in a research note to investors on Thursday, August 22nd. Finally, analysts at Jefferies Group raised their price target on shares of Medidata Solutions from $75.00 to $105.00 in a research note to investors on Friday, July 26th. They now have a “buy” rating on the stock. One analyst has rated the stock with a hold rating and four have assigned a buy rating to the stock. Medidata Solutions presently has an average rating of “Buy” and an average price target of $84.73.
Medidata Solutions (NASDAQ:MDSO) traded down 1.20% during mid-day trading on Tuesday, hitting $104.77. 311,584 shares of the company’s stock traded hands. Medidata Solutions has a one year low of $31.30 and a one year high of $99.79. The stock’s 50-day moving average is $89.9 and its 200-day moving average is $71.32. The company has a market cap of $2.690 billion and a price-to-earnings ratio of 128.07.
Medidata Solutions (NASDAQ:MDSO) last issued its quarterly earnings data on Thursday, July 25th. The company reported $0.20 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.12 by $0.08. The company had revenue of $68.07 million for the quarter, compared to the consensus estimate of $66.71 million. During the same quarter in the prior year, the company posted $0.23 earnings per share. The company’s quarterly revenue was up 27.2% on a year-over-year basis. Analysts expect that Medidata Solutions will post $1.37 EPS for the current fiscal year.
Medidata Solutions, Inc (NASDAQ:MDSO) is a global provider of software-as-a-service (SaaS), clinical technology solutions.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.